Capital Fund Management (CFM)
ABMD

Capital Fund Management (CFM)’s Abiomed Inc ABMD Stock Holding History

Capital Fund Management (CFM)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,900
Closed -$1.23M – 2091
2019
Q3 		$1.23M Buy
6,900
+2,600
+60% +$562K 0.01% 952
2019
Q2 		$1.12M Buy
+4,300
New +$1.14M 0.01% 984
2019
Q1 		– Sell
-2,800
Closed -$910K – 2199
2018
Q4 		$910K Sell
2,800
-6,800
-71% -$2.36M 0.01% 1127
2018
Q3 		$4.32M Hold
9,600
– – 0.02% 826
2018
Q2 		$3.93M Sell
9,600
-700
-7% -$254K 0.02% 831
2018
Q1 		$3M Buy
+10,300
New +$2.61M 0.02% 858
2017
Q1 		– Sell
-1,800
Closed -$203K – 1929
2016
Q4 		$203K Buy
+1,800
New +$209K ﹤0.01% 1574

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capital Fund Management (CFM)'s ABMD Position: Q4 2022 in Review

Capital Fund Management (CFM) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 36,772 shares — an estimated $9.03M sold.

Capital Fund Management (CFM) first reported a position in ABMD in Q2 2014 and held it in 21 quarters. The position peaked at $13.3M in Q4 2015. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Capital Fund Management (CFM) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 36,772 Abiomed Inc shares in Q4 2022, an estimated $9.03M.
  • Capital Fund Management (CFM) first reported a position in Abiomed Inc in Q2 2014 and held it in 21 quarters.
  • Capital Fund Management (CFM)'s Abiomed Inc position peaked at $13.3M in Q4 2015.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2022, filed 13 Feb 2023.